By Associated Press | Associated Press, Washington
UPDATED ON JUN 26, 2018 10:21 AM IST
British drugmaker GW Pharmaceuticals studied the drug in more than 500 children and adults with hard-to-treat seizures.
Enter your email to get our daily newsletter in your inbox
Get our daily newsletter in your inbox
Thank you for subscribing to our daily newsletter.